Search research articles
Contact Us
Filters
Showing results (21-30 of 163) with videos related to
Page
of 17
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 11, 2006
Adeno-associated virus serotypes: vector toolkit for human gene therapy
Zhijian Wu, Aravind Asokan, R Jude Samulski
Bio-Protocol
|
June 29, 2018
Nab Escaping AAV Mutants Isolated from Mouse Muscles
Zheng Chai, R Jude Samulski, Chengwen Li
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 26, 2012
The AAV vector toolkit: poised at the clinical crossroads
Aravind Asokan, David V Schaffer, R Jude Samulski
Journal of Virology
|
February 15, 2013
Arsenic trioxide stabilizes accumulations of adeno-associated virus virions at the perinuclear region, increasing transduction in vitro and in vivo
Angela M Mitchell, Chengwen Li, R Jude Samulski
Human Gene Therapy
|
August 25, 2020
Adeno-Associated Virus Vector Mobilization, Risk Versus Reality
Liujiang Song, R Jude Samulski, Matthew L Hirsch
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 16, 2016
AAVR: A Multi-Serotype Receptor for AAV
Candace Summerford, Jarrod S Johnson, R Jude Samulski
Current Gene Therapy
|
November 8, 2013
Biosafety of recombinant adeno-associated virus vectors
David J Dismuke, Liliane Tenenbaum, R Jude Samulski
Journal of Virology
|
December 13, 2002
Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production
Dawn E Bowles, Joseph E Rabinowitz, R Jude Samulski
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 21, 2013
Parkinson's disease gene therapy: success by design meets failure by efficacy
Raymond T Bartus, Marc S Weinberg, R Jude Samulski
Annual Review of Genetics
|
December 1, 2004
Integration of adeno-associated virus (AAV) and recombinant AAV vectors
Douglas M McCarty, Samuel M Young, R Jude Samulski
Page
of 17
Search research articles
Search
Showing results (21-30 of 163) with videos related to
Sort By:
Page
of 17
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 11, 2006
Adeno-associated virus serotypes: vector toolkit for human gene therapy
Zhijian Wu, Aravind Asokan, R Jude Samulski
Bio-Protocol
|
June 29, 2018
Nab Escaping AAV Mutants Isolated from Mouse Muscles
Zheng Chai, R Jude Samulski, Chengwen Li
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 26, 2012
The AAV vector toolkit: poised at the clinical crossroads
Aravind Asokan, David V Schaffer, R Jude Samulski
Journal of Virology
|
February 15, 2013
Arsenic trioxide stabilizes accumulations of adeno-associated virus virions at the perinuclear region, increasing transduction in vitro and in vivo
Angela M Mitchell, Chengwen Li, R Jude Samulski
Human Gene Therapy
|
August 25, 2020
Adeno-Associated Virus Vector Mobilization, Risk Versus Reality
Liujiang Song, R Jude Samulski, Matthew L Hirsch
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 16, 2016
AAVR: A Multi-Serotype Receptor for AAV
Candace Summerford, Jarrod S Johnson, R Jude Samulski
Current Gene Therapy
|
November 8, 2013
Biosafety of recombinant adeno-associated virus vectors
David J Dismuke, Liliane Tenenbaum, R Jude Samulski
Journal of Virology
|
December 13, 2002
Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production
Dawn E Bowles, Joseph E Rabinowitz, R Jude Samulski
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 21, 2013
Parkinson's disease gene therapy: success by design meets failure by efficacy
Raymond T Bartus, Marc S Weinberg, R Jude Samulski
Annual Review of Genetics
|
December 1, 2004
Integration of adeno-associated virus (AAV) and recombinant AAV vectors
Douglas M McCarty, Samuel M Young, R Jude Samulski
Page
of 17